The Role of GM3, a Glycosphingolipid, as a Modulator of Skeletal Muscle Insulin Sensitivity

Project Details

StatusFinished
Effective start/end date1/10/11 → 31/01/15

Funding

  • Diabetes UK (10/0004146): £84,431.00
  • Diabetes UK (10/0004146): £84,431.00